Genetics of Blood Proteins: QMUL Largest Study | AcademicJobs UK
Queen Mary University of London's landmark study on genetics of blood proteins reveals new disease insights and repurposing opportunities like TYK2 for RA.
No reviews yet. Be the first to rate Mine!
Dr. Mine Koprulu is Senior Post-doctoral Researcher in Genomics at the Precision Healthcare University Research Institute at Queen Mary University of London. She holds a BSc in Human Genetics from University College London. She completed an MPhil in Genomic Medicine at the University of Cambridge as a Gates Cambridge Scholar. During her master’s research project at the Wellcome Sanger Institute, she investigated the genetic basis of complex traits and diseases using genomics data from UK Biobank and whole genome sequencing data from population isolates. She also gained experience identifying the genetic basis of rare human diseases as a research scientist at Bogazici University and Istanbul Technical University in Turkey. Dr. Koprulu completed her PhD at the MRC Epidemiology Unit at the University of Cambridge as a Gates Scholar. Her doctoral work focused on causal gene prioritization for diverse diseases through large-scale multi-omics data integration.
Her research interests focus on improving the understanding of biological mechanisms underlying diverse diseases through genomics and multi-omics data for translation of biological findings into clinically actionable insights. In her current role at Queen Mary University of London she contributes to multi-omics research within the Precision Healthcare University Research Institute.
Queen Mary University of London's landmark study on genetics of blood proteins reveals new disease insights and repurposing opportunities like TYK2 for RA.